Celeste M Boesjes

12PUBLICATIONS
39CO-AUTHORS
AllergyPharmacogenomicsGene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 16, 2026
Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin-Homing T Cells of Atopic Dermatitis Patients.

|Dec 09, 2025
Drug Survival in Atopic Dermatitis: Comparison of Biologics and JAK Inhibitors in the BioDay Registry.

Lian F van der Gang, Celeste M Boesjes, Nicolaas P A Zuithoff

|Sep 24, 2025
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions.

Marjolein S de Bruin-Weller, Celeste M Boesjes, Roselie A Achten

|Apr 03, 2025
Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors: BioDay results.

Lian F van der Gang, Keneshka Atash, Nicolaas P A Zuithoff

|Feb 05, 2025
Increased Levels of Inflammatory Proteins, Including TARC/CCL17, in Skin of AD Patients During JAK Inhibitor Treatment.

Celeste M Boesjes, Lian F van der Gang, Daphne S Bakker

Pageof 2